Unfractionated heparin dosing in obese patients-Reference-Cited by-同舟云学术

Unfractionated heparin dosing in obese patients

Published:2020-03-05 Issue:2 Volume:42 Page:462-473
ISSN:2210-7703
Container-title:International Journal of Clinical Pharmacy
language:en
Short-container-title:Int J Clin Pharm

Author:

George Christopher,Barras Michael,Coombes Judith,Winckel Karl

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology,Toxicology,Pharmacy

Link

http://link.springer.com/content/pdf/10.1007/s11096-020-01004-5.pdf

Reference31 articles.

1. Hirsh J, Raschke R. Heparin and low-molecular-weight heparin: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest. 2004;126(3 Suppl):188s–203s. https://doi.org/10.1378/chest.126.3_suppl.188S.

2. Australian Bureau of Statistics. Overweight and obesity. In: national health survey: first results, 2014–15. ABN Catalouge no. 4364.0.55.001: Canberra: Australian government; 2015.

3. Haby MM, Markwick A, Peeters A, Shaw J, Vos T. Future predictions of body mass index and overweight prevalence in Australia, 2005-2025. Health Promot Int. 2012;27(2):250–60. https://doi.org/10.1093/heapro/dar036.

4. Kandrotas RJ. Heparin pharmacokinetics and pharmacodynamics. Clin Pharmacokinet. 1992;22(5):359–74. https://doi.org/10.2165/00003088-199222050-00003.

5. Verstraete M. Pharmacotherapeutic aspects of unfractionated and low molecular weight heparins. Drugs. 1990;40(4):498–530.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical guidance for unfractionated heparin dosing and monitoring in critically ill patients;Expert Opinion on Pharmacotherapy;2024-05-23

2. In‐depth multiomic characterization of the effects of obesity in high‐fat diet‐fed mice;FEBS Open Bio;2024-03-13

3. Impact of augmented renal clearance on anticoagulant therapy in critically ill patients with coronavirus disease 2019: A retrospective cohort study;Journal of Infection and Chemotherapy;2024-02

4. Safety of fixed-dose heparin titration boluses in underweight patients;Thrombosis Research;2024-01

5. Laboratory Monitoring of Heparin Anticoagulation in Hemodialysis: Rationale and Strategies;Seminars in Nephrology;2023-11